Loading...
Citizens Bancshares (CZBS, $39.5) was a top loser over the last three months, falling -1 to $39.5 per share. A.I.dvisor analyzed 877 stocks in the Regional Banks Industry for the 3-month period ending November 24, 2025, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.
The Aroon Indicator for CZBS entered a downward trend on November 18, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 147 similar instances where the Aroon Indicator formed such a pattern. In of the 147 cases the stock moved lower. This puts the odds of a downward move at .
The Momentum Indicator moved below the 0 level on November 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CZBS as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CZBS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CZBS's RSI Oscillator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for CZBS just turned positive on November 14, 2025. Looking at past instances where CZBS's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CZBS advanced for three days, in of 173 cases, the price rose further within the following month. The odds of a continued upward trend are .
CZBS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 52, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.934) is normal, around the industry mean (1.110). P/E Ratio (8.082) is within average values for comparable stocks, (18.023). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.173). Dividend Yield (0.027) settles around the average of (0.036) among similar stocks. P/S Ratio (1.857) is also within normal values, averaging (5.170).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly weaker than average sales and a marginally profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CZBS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Industry RegionalBanks